Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

EHA 2016 | The importance of recgonizing different DLBCL subtypes

Georg Lenz • 9 Jun 2016
EHA 2016
B-Cell Lymphoma Non-Hodgkin Lymphoma

Georg Lenz from the University of Münster, Münster, Germany discusses diffuse large B-cell lymphoma (DLBCL) at the European Hematology Association (EHA) 2016 Annual Congress in Copenhagen, Denmark. Researchers have found that there are many different DLBCL subtypes, for examples the ACB and the GCB subtype. Prof. Lenz stresses the importance of recognizing these different subtypes in respect to diagnosis and treatment.

More from Georg Lenz

Tafasitamab, lenalidomide, and R-CHOP in frontline high-risk DLBCL: the Phase III frontMIND trial
1:28
Tafasitamab, lenalidomide, and R-CHOP in frontline high-risk DLBCL: the Phase III frontMIND trial
Georg Lenz • 13 Jun 2026
Update from the Lenz lab in Münster
1:29
Update from the Lenz lab in Münster
Georg Lenz • 20 Jun 2019
DLBCL research to watch
0:55
DLBCL research to watch
Georg Lenz • 20 Jun 2019
Can we improve on R-CHOP for the frontline treatment of DLBCL?
1:26
Can we improve on R-CHOP for the frontline treatment of DLBCL?
Georg Lenz • 20 Jun 2019

Related Videos

Exploring CAR-T and bispecifics in CLL: novel approaches beyond BTK and BCL2 inhibitors
2:30
Exploring CAR-T and bispecifics in CLL: novel approaches beyond BTK and BCL2 inhibitors
Alexey Danilov • 16 Oct 2026
Genomic and immune signatures of ibrutinib response & resistance in Waldenström's macroglobulinemia
2:39
Genomic and immune signatures of ibrutinib response & resistance in Waldenström's macroglobulinemia
Tina Bagratuni • 23 Sep 2026
Unresolved questions in T-cell lymphoma: individualized therapy and access to new technologies
2:13
Unresolved questions in T-cell lymphoma: individualized therapy and access to new technologies
Mary Jo Lechowicz • 11 Sep 2026
Key advances in FL management expected to change practice over the next five years
1:26
Key advances in FL management expected to change practice over the next five years
Kim Linton • 11 Sep 2026

Choose your cookie settings

VJHemOnc uses necessary cookies to make the site work. With your permission we'd also like to use analytics, preference and marketing cookies to understand how the site is used and improve it.

Choose an option to continue. You can change it at any time on our Cookie Policy page, linked at the bottom of every page.

Cookie Policy (opens in a new tab)
The content of VJHemOnc is intended for healthcare professionals